GSK's Romanian unit tools up to make Seroxat, Retrovir; AZ to cease ops at U.K. plant;

 @FiercePharma: FDA staffers back Pfizer's Prevnar 13 vax for adults; advisory committee meets Wednesday. News | Follow @FiercePharma

> GlaxoSmithKline's ($GSK) Romanian unit is investing $7 million to add production lines to its plant in Brasov, to make way for manufacturing its antidepressant Seroxat and its HIV treatment Retrovir. Report

> AstraZeneca ($AZN) said operations at its plant in Loughborough, England, will cease at the end of the month as local officials seek a buyer or tenant for the 69-acre property. Story

> Increasing the dosage of the blood thinner Plavix in patients with a genetic variation improves response to the Sanofi/Bristol-Myers Squibb drug. Release

> United Drug is vying for contract packaging deals in Europe as outsourcing widens. News

> Vascular markers support lupus treatment. News

> GlaxoSmithKline ($GSK) is stirring up more opposition to its proposal for two wind turbines that would help power a plant in Scotland. Item

> Stevenson University bought a Shire Pharmaceuticals plant in Baltimore for $10.5 million to expand its campus. Story

> Exercise cuts breast cancer markers. News

> Pfizer ($PFE) has nabbed a site in Saudi Arabia for a new manufacturing facility to produce drugs for domestic and international markets. Piece

> Patients taking antidepressants and antipsychotic drugs have a higher risk of dying during a heart attack. Report

Biotech News

 @FierceBiotech: GSK's albiglutide flunks head-to-head diabetes PhIII with rival Victoza. Article | Follow @FierceBiotech

 @JohnCFierce: New PwC survey: Close to half of Americans didn't get care or take a drug due to out-of-pocket cost in last year. Release | Follow @JohnCFierce

 @RyanMFierce: Roche has tapped biotech Aileron for stapled peptide tech in inflammatory diseases, no financial details though. Release | Follow @RyanMFierce

 @MarkHFierce: Walgreens pharmacists and hospitals are teaching patients how to understand their new drugs before going home. Story | Follow @MarkHFierce

> Biotech VCs back startup Allena Pharma in $15M A round. News

> Gilead Sciences, J&J up the ante on new HIV drug combos. Story

Medical Device News

> Sera lands $19.3M, appoints Critchfield as CEO. More

> Study: Corus CAD demonstrates superiority to MPI. Item

> Accuray to cut 5% of workforce. Article

> Varian gains on word of Siemens' 'selective exit' from radiation therapy. News

Drug Delivery News

> Medgenics proceeds with biopump anemia treatment. Story

> Merck licenses Bend Research's spray-dried dispersion tech. Article

> New class of drugs may kill tumors by altering structure of crucial enzyme. More

> Cerulean Pharma enrolling for Phase 2 lung cancer trial. Piece

And Finally... U.S. patients who don't have insurance are discharged from the hospital sooner than those who are covered, a study found. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.